Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ORIC
ORIC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ORIC News
ORIC Pharmaceuticals Grants Stock Options and RSUs to New Employees
4d ago
Newsfilter
Pomerantz LLP Investigates ORIC Pharmaceuticals for Securities Fraud
May 21 2026
PRnewswire
Pomerantz LLP Investigates Securities Fraud Claims Against ORIC Pharmaceuticals
May 19 2026
Globenewswire
Wall Street's Latest Upgrade Calls Overview
May 15 2026
CNBC
Pomerantz LLP Investigates Securities Fraud Claims Against ORIC Pharmaceuticals
May 15 2026
PRnewswire
Pomerantz LLP Investigates Securities Fraud Claims Against ORIC Pharmaceuticals
May 12 2026
Globenewswire
Pomerantz Investigates ORIC Pharmaceuticals for Securities Fraud
May 01 2026
PRnewswire
Pomerantz LLP Investigates ORIC Pharmaceuticals for Securities Fraud
Apr 28 2026
Globenewswire
Pomerantz LLP Investigates Securities Fraud Claims Against ORIC Pharmaceuticals
Apr 21 2026
Globenewswire
US Stocks Close Higher Amid Optimism Over Middle East Conflict Resolution
Apr 01 2026
NASDAQ.COM
Oric Pharmaceuticals Shares Plunge 28% Amid Safety Concerns
Apr 01 2026
stocktwits
US Stocks Rise on Optimism Over Middle East Conflict Resolution
Apr 01 2026
NASDAQ.COM
US Stocks Rise on Optimism Over Middle East Conflict Resolution
Apr 01 2026
NASDAQ.COM
Oric Pharmaceuticals Reports New Rinzimetostat Developments
Apr 01 2026
NASDAQ.COM
ORIC Pharmaceuticals Shares Drop After Rinzimetostat Trial Data Release
Apr 01 2026
seekingalpha
ORIC Pharmaceuticals Faces Safety Concerns in Drug Trial
Apr 01 2026
stocktwits
Show More News
